スポンサーリンク
Department Of Urology Yokohama City University Graduate School Of Medicine | 論文
- GnRH analog, leuprorelin acetate, promotes regeneration of rat spermatogenesis after severe chemical damage
- Infrequent genetic alterations of the PTEN gene in Japanese patients with sporadic prostate cancer
- Testosterone administration promotes regeneration of chemically impaired spermatogenesis in rats
- Improvement on parenchymal suturing technique in laparoscopic partial nephrectomy
- Usefulness of ultrasensitive prostate-specific antigen assay for early detection of biochemical failure after radical prostatectomy
- Primary testicular leiomyosarcoma
- Proliferation of spermatogonial stem stem cells and spermatogenesis in vitro
- Derivation and morphological characterization of mouse spermatogonial stem cell lines
- Clinical Evaluation of Choline Measurement by Proton MR Spectroscopy in Patients with Malignant Tumors
- Melatonin accelerates reentrainment of circadian locomotor activity rhythms to new light-dark cycles in the rat
- The Niche for Spermatogonial Stem Cells in the Mammalian Testis
- 103 (22 腎・泌尿器(3))
- F-18 FDG PET/CT evaluation of radiotherapy response in rare case of mucosa-associated lymphoid tissue lymphoma
- Pharmacology and new perspectives of angiotensin II receptor blocker in prostate cancer treatment
- Effectiveness of percent free prostate specific antigen as a predictor of prostate cancer detection on repeat biopsy
- SCHEDULE-INTENSIFIED M-VAC CHEMOTHERAPY FOR ADVANCED UROTHELIAL CANCER WITH RECOMBINANT HUMAN GRANULOCYTE COLONY STIMULATING FACTOR (rhG-CSF)
- Self-sterilizing catheters with titanium dioxide photocatalyst thin films for clean intermittent catheterization : Basis and study of clinical use
- Epithelioid angiomyolipoma of the kidney
- Complete response, as determined by prostate-specific antigen level, to chlormadinone acetate withdrawal persisting longer than 2 years in patients with advanced prostate cancer : Two case reports
- Inhibition of PSA flare in prostate cancer patients by asmimistration of flutamide for 2 weeks before initiation of treatment with slow-releasing